Profile data is unavailable for this security.
About the company
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. The Company’s segments include CMO activities and Integrated Eye-care pharmaceutical company. Its contract manufacturing operations include LSL Laboratory, Inc., Dermolab Pharma Ltd., Virage Sante Inc., and Laboratoire Du-Var Inc. LSL Laboratory, Inc. is engaged in the manufacturing of natural health products in solid dosage forms. Dermolab Pharma Ltd. manufactures liquid and semi-solid pharmaceutical, natural health and cosmetic products. Steri-Med Pharma Inc., the Company’s sterile eye-care manufacturing operation, specializes in the in-licensing or development/manufacturing and commercialization of sterile ophthalmic pharmaceuticals for Canada, United States and other international markets.
- Revenue in CAD (TTM)26.80m
- Net income in CAD2.78m
- Incorporated2010
- Employees--
- LocationLSL Pharma Group Inc540, rue d'Avaugour, Office 1800BOUCHERVILLE J4B 0G6CanadaCAN
- Phone+1 (450) 681-7744
- Fax+1 (450) 681-8400
- Websitehttps://www.groupelslpharma.com/
Mergers & acquisitions
| Acquired company | LSL:CVE since announced | Transaction value |
|---|---|---|
| Juno OTC Inc | 42.86% | 3.58m |
| Laboratoire Du-Var Inc | 42.86% | 2.28m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacielo Ltd | 2.83m | -6.42m | 13.15m | 268.00 | -- | -- | -- | 4.66 | -0.0356 | -0.0356 | 0.0156 | -0.0795 | 0.1994 | 1.71 | 4.10 | -- | -45.28 | -- | -- | -- | 3.13 | -- | -227.15 | -- | 0.0907 | -3.01 | 6.18 | -- | -- | -- | -- | -- | -- | -- |
| Simply Solventless Concentrates Ltd | 30.71m | 4.17m | 17.90m | 192.00 | 8.79 | 0.5605 | 3.07 | 0.583 | 0.0176 | 0.0176 | 0.2643 | 0.2765 | 0.725 | 1.11 | 7.89 | 159,949.40 | 9.84 | -- | 13.15 | -- | 28.99 | -- | 13.57 | -- | 0.7405 | -0.5981 | 0.3241 | -- | 120.93 | -- | -599.34 | -- | -- | -- |
| Voyageur Pharmaceuticals Ltd | 11.04k | -3.13m | 25.00m | -- | -- | 17.31 | -- | 2,264.69 | -0.0197 | -0.0197 | 0.00007 | 0.0081 | 0.0037 | 0.17 | 0.1428 | -- | -103.95 | -78.90 | -250.45 | -135.25 | -25.63 | -- | -28,307.25 | -- | 0.5081 | -- | 0.027 | -- | -- | -- | -21.99 | -- | -1.10 | -- |
| Decibel Cannabis Company Inc | 109.31m | 12.32m | 54.82m | -- | 3.60 | 0.8619 | 2.83 | 0.5015 | 0.0264 | 0.025 | 0.198 | 0.1102 | 0.795 | 2.15 | 6.51 | -- | 8.96 | -0.0401 | 13.94 | -0.0595 | 21.98 | 20.03 | 11.27 | -0.0688 | 0.6086 | -5.57 | 0.4186 | -- | -12.89 | 71.51 | 810.61 | -- | -4.74 | -- |
| Eastwood Bio-Medical Canada Inc | 594.57k | -411.84k | 55.11m | -- | -- | -- | -- | 92.69 | -0.006 | -0.006 | 0.0086 | -0.0225 | 2.17 | -- | 26.00 | -- | -150.26 | -71.29 | -- | -- | 63.91 | 56.40 | -69.27 | -57.09 | -- | -31.24 | -- | -- | -19.11 | -11.50 | 16.60 | -- | -- | -- |
| LSL Pharma Group Inc | 26.80m | 2.78m | 63.36m | -- | 20.82 | 2.39 | 12.59 | 2.36 | 0.024 | 0.024 | 0.2307 | 0.2094 | 0.5462 | 1.98 | 5.78 | -- | 5.65 | -- | 7.29 | -- | 29.73 | -- | 10.35 | -- | 0.5366 | 0.6521 | 0.5325 | -- | 76.98 | -- | 139.15 | -- | -- | -- |
| Arch Biopartners Inc | 275.95k | -1.55m | 63.59m | -- | -- | -- | -- | 230.43 | -0.0237 | -0.0237 | 0.0042 | -0.0587 | 0.5306 | -- | 0.7616 | -- | -298.56 | -195.50 | -- | -- | -- | -- | -562.69 | -123.23 | -- | -3.99 | -- | -- | -87.00 | 32.37 | 60.39 | -- | -- | -- |
| Medexus Pharmaceuticals Inc | 135.40m | -370.38k | 92.41m | 91.00 | -- | 1.30 | 7.19 | 0.6825 | -0.0142 | -0.0142 | 4.25 | 2.20 | 0.6608 | 1.40 | 7.68 | 1,487,904.00 | -0.1808 | -3.71 | -0.3159 | -6.22 | 53.87 | 52.71 | -0.2736 | -5.74 | 0.6197 | 1.23 | 0.3268 | -- | -4.18 | 14.31 | 1,150.00 | -- | 24.90 | -- |
